1DM4 image
Entry Detail
PDB ID:
1DM4
Keywords:
Title:
SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16)
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
1999-12-13
Release Date:
2000-01-19
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Observed:
0.16
Space Group:
I 21 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:PROTEIN (ALPHA THROMBIN:LIGHT CHAIN)
Chain IDs:A
Chain Length:35
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:PROTEIN (MUTANT ALPHA THROMBIN:HEAVY CHAIN)
Mutations:S195A
Chain IDs:B
Chain Length:260
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structure of the Ser195Ala mutant of human alpha--thrombin complexed with fibrinopeptide A(7--16): evidence for residual catalytic activity.
Acta Crystallogr.,Sect.D 56 406 410 (2000)
PMID: 10739913 DOI: 10.1107/S0907444900001487

Abstact

The Ser195Ala mutant of human alpha-thrombin was complexed with fibrinopeptide A(7-22) (FPA) in an effort to describe the (P1'-P6') post-cleavage binding subsites of the fibrinogen-recognition exosite and define more clearly the nature of the Michaelis complex and the scissile peptide bond bound at the catalytic site. The thrombin mutant, however, has residual catalytic activity and proteolysis occurred at the Arg16-Gly17 bond. Thus, the structure of the thrombin complex determined was that of FPA(7-16) bound at the active site, which is very similar to the ternary FPA(7-16)cmk-human thrombin-hirugen complex (r.m.s.d. approximately 0.4 A; Stubbs et al. , 1992). It is further shown by subsidiary experiments that the cleavage is the result of residual catalytic activity of the altered catalytic machinery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures